Ultraviolet recall associated with etoposide and cyclophosphamide therapy.
Ultraviolet recall (UR) or sunburn reactivation is an infrequently reported phenomenon. It is characterized by an erythematous eruption in the distribution of previous ultraviolet-induced sunburn. The timing of the eruption correlates well with the speculation that it is induced by the administration of a chemotherapeutic agent(s). The case of a young man who developed UR after treatment with etoposide (VP16) and cyclophosphamide is reported.
Williams
B J
BJ
Indiana University, School of Medicine, Indianapolis.
Roth
D J
DJ
Callen
J P
JP
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects; D001761:Bleomycin / Q000009:adverse effects; D003520:Cyclophosphamide / Q000009:adverse effects*; D003907:Dexamethasone / Q000009:adverse effects; D004317:Doxorubicin / Q000009:adverse effects; D003875:Drug Eruptions / Q000209:etiology*; D005047:Etoposide / Q000009:adverse effects*; D006801:Humans; D002955:Leucovorin / Q000009:adverse effects; D008297:Male; D008727:Methotrexate / Q000009:adverse effects; D011239:Prednisolone / Q000009:adverse effects; D012008:Recurrence; D013471:Sunburn / Q000209:etiology*; D014750:Vincristine / Q000009:adverse effects
D001761:Bleomycin; D014750:Vincristine; D005047:Etoposide; D003907:Dexamethasone; D004317:Doxorubicin; D003520:Cyclophosphamide; D011239:Prednisolone; D002955:Leucovorin; D008727:Methotrexate